Kathryn E. Carlson
Papers
1
Total Citations
41
H-Index
1
About
Kathryn E. Carlson is a leading expert in nuclear hormone receptor (NHR) pharmacology, with a career dedicated to unraveling how these ligand-modulated transcription factors govern development and homeostasis. Her most influential work introduced a groundbreaking proteomic microarray approach that revolutionized the study of NHRs, enabling researchers to simultaneously probe ligand-initiated receptor selectivity, heterodimer functionality, and complex signaling dynamics. This innovation, detailed in her highly cited 2004 paper (41 citations), provided a high-throughput platform for mapping the intricate interactions between hormones, synthetic analogs, and their receptors—a critical advance for understanding diseases like cancer and metabolic disorders. By moving beyond traditional single-receptor assays, Carlson’s methodology illuminated how subtle changes in ligand structure can shift receptor activation profiles, offering new avenues for targeted drug design. Her contributions have been instrumental in bridging basic endocrinology with translational pharmacology, earning her recognition as a pioneer in proteomic tools for hormone research. For students and researchers, her work exemplifies how creative assay design can unlock the complexity of biological regulation, making her a key figure in the evolution of nuclear receptor science.
Research Focus
Key Achievements
Top Papers
- 1